CHAPIN DAVIS, INC.

Position in DYAI — Dyadic International Inc

CIK 872098 BALTIMORE, MD

Position in DYAI

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$799,203

+$71,040 QoQ

Shares Held

888,004

0.0% QoQ

Ownership

2.44%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

of 39 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CHAPIN DAVIS, INC. holds $1,662,100 across 5 Biotechnology names. DYAI ranks #1 (48.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DYAI	Dyadic International Inc This page	888,004	$799,203
2	TRVI	Trevi Therapeutics, Inc.	20,100	$374,865
3	ALNY	Alnylam Pharmaceuticals, Inc.	850	$255,875
4	BEAM	Beam Therapeutics Inc.	6,000	$205,920
5	LCTX	Lineage Cell Therapeutics, Inc.	20,029	$26,237

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$799,203	888,004	0.0%	Shares	Sole	2026-07-07
2026-03-31	$728,163	888,004	0.0%	Shares	Sole	2026-04-21
2025-12-31	$834,723	888,004	-4.7%	Shares	Sole	2026-01-30
2025-09-30	$1,099,764	932,004	+5.6%	Shares	Sole	2025-10-09
2025-06-30	$874,020	882,849	+4.7%	Shares	Sole	2025-07-14
2025-03-31	$1,137,846	842,849	-2.9%	Shares	Sole	2025-04-23
2024-12-31	$1,519,526	868,301	0.0%	Shares	Sole	2025-01-21
2024-09-30	$903,033	868,301	+2.5%	Shares	Sole	2024-10-07
2024-06-30	$1,254,005	847,301	+2.5%	Shares	Sole	2024-07-19
2024-03-31	$1,379,922	826,301	0.0%	Shares	Sole	2024-04-18
2023-12-31	$1,330,344	826,301	-1.4%	Shares	Sole	2024-01-11
2023-09-30	$1,609,537	838,301	+0.7%	Shares	Sole	2023-10-19
2023-06-30	$1,606,340	832,301	+1.1%	Shares	Sole	2023-08-30
2023-03-31	$1,465,475	823,301	+0.4%	Shares	Sole	2023-04-13
2022-12-31	$1,008,143	819,629	—	Shares	Sole	2023-01-30
No filing history on record for this holder in this stock.